BiaCure is developing a medical device that uses its patented BiaPulse high‑frequency energy technology to eradicate onychomycosis infections while protecting surrounding tissue. The system features a reusable energy source that can treat two toes simultaneously and custom‑made applicators generated from ultrasound scans and a proprietary AI algorithm to match each patient’s nail geometry.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Onychomycosis affects over 35 million people in the United States, causing disfiguring, painful nail infections that can lead to secondary foot problems, especially in diabetic patients. Existing treatments—topical agents, oral antifungals, and limited medical devices—have low cure rates, significant safety concerns, or are not approved for therapeutic use.
Solution
BiaCure’s BiaPulse™ system delivers high‑frequency energy (HFE) directly to the infected nail plate and nail bed to eradicate fungal pathogens while sparing surrounding tissue. Custom‑fit applicators are generated from ultrasound scans of each toe and shaped by a proprietary AI algorithm, ensuring precise energy delivery that conforms to nail size, thickness, and disease extent. The device treats two toes simultaneously and incorporates real‑time temperature monitoring to maintain patient safety within FDA‑defined limits. By targeting the infection at its source, BiaPulse™ aims to provide a safer, more effective alternative to oral antifungals and ineffective topicals.
Target Audience
Primary customers are podiatrists, dermatologists, and foot‑care clinics that treat onychomycosis, particularly those serving diabetic or high‑risk patient populations.
Features
- Re‑usable HFE energy source capable of concurrent treatment of two toes
- Patient‑specific applicators produced from ultrasound scans and AI‑driven 3D modeling to match nail geometry
- Integrated temperature control system that automatically regulates toe temperature during therapy
- High‑frequency energy delivery focused on nail plate and bed, minimizing exposure to surrounding tissue
- Designed for clinical use with a treatment protocol that aligns with FDA safety labeling